[{"Assets_0_Q3_USD":370469000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":11666000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":11677000.0,"StockholdersEquity_0_Q3_USD":182801000.0,"RevenuesConverted_3_Q3_USD":129556000.0,"RevenuesConverted_1_Q3_USD":48164000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":11553000.0,"NetIncomeLossConverted_1_Q3_USD":4720000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":23614000.0,"EarningsPerShareDiluted_3_Q3_USD":0.73,"EarningsPerShareDiluted_1_Q3_USD":0.4,"EarningsPerShareBasic_3_Q3_USD":0.74,"EarningsPerShareBasic_1_Q3_USD":0.41,"NetIncomeLossConverted_3_Q3_USD":8553000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":11542000.0,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171102"}]